The Relationship Between Anxiety Disorders and Parkinson’s Disease: Clinical and Therapeutic Issues

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Current Psychiatry Reports

• Publication date

  2021-03-03

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s11920-021-01229-9PMID 33660146
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Individually Tailored Internet-Based Cognitive-Behavioral Therapy for Daily Functioning in Patients with Parkinson’s Disease: A Randomized Controlled Trial

  2020cited by this paper
• Functional outcomes of an integrated Parkinson's Disease Wellbeing Program

  2020cited by this paper
• Mild cognitive impairment, psychiatric symptoms, and executive functioning in patients with Parkinson's disease

  2020cited by this paper
• Telephone-based cognitive behavioral therapy for depression in Parkinson disease

  2020cited by this paper
• Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review

  2019cited by this paper
• Non-motor predictors of freezing of gait in Parkinson's disease.

  2019cited by this paper
• Worse Cognitive Performance Predicts Increased Anxiety and Depressive Symptoms in Patients With Parkinson’s Disease: A Bidirectional Analysis

  2019cited by this paper
• Anxiety Independently Contributes to Severity of Freezing of Gait in People With Parkinson's Disease.

  2019cited by this paper
• Yoga Improves Balance and Low-Back Pain, but Not Anxiety, in People with Parkinson's Disease.

  2019cited by this paper
• Impacts of dance on cognition, psychological symptoms and quality of life in Parkinson’s disease

  2019cited by this paper
• Potential predictors of quality of life in Parkinson's Disease: Sleep and mood disorders.

  2019cited by this paper
• Longitudinal assessment of autonomic dysfunction in early Parkinson's disease.

  2019cited by this paper
• Restless Legs Syndrome in Parkinson's Disease Patients: Clinical Features Including Motor and Nonmotor Symptoms

  2019cited by this paper
• The Effects of Music-Contingent Gait Training on Cognition and Mood in Parkinson Disease: A Feasibility Study

  2019cited by this paper
• Predictors of motor complications in early Parkinson's disease: A prospective cohort study

  2019cited by this paper
• The Longitudinal Impact of Excessive Daytime Somnolence on Motor and Nonmotor Symptoms of Parkinson's Disease in a Southeast Asian Cohort

  2019cited by this paper
• Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson’s disease

  2019cited by this paper
• Treatment of psychiatric disturbances in hypokinetic movement disorders

  2019cited by this paper
• The effects of cognitive behavioral and mindfulness-based therapies on psychological distress in patients with multiple sclerosis, Parkinson's disease and Huntington's disease: Two meta-analyses.

  2019cited by this paper
• Predictors of health-related quality of life in Parkinson's disease.

  2019cited by this paper
• "Pseudo-syndromes" associated with Parkinson disease, dementia, apathy, anxiety, and depression.

  2019cited by this paper
• Descriptive analysis of the French NS-Park registry: Towards a nation-wide Parkinson's disease cohort?

  2019cited by this paper
• The Neuropsychiatry of Parkinson Disease: A Perfect Storm.

  2019cited by this paper
• Effects of Mindfulness Yoga vs Stretching and Resistance Training Exercises on Anxiety and Depression for People With Parkinson Disease: A Randomized Clinical Trial.

  2019cited by this paper
• Predicting diagnosis of Parkinson's disease: A risk algorithm based on primary care presentations

  2019cited by this paper
• Measuring Anxiety in Patients With Early-Stage Parkinson's Disease: Rasch Analysis of the State-Trait Anxiety Inventory

  2019cited by this paper
• Improved understanding, detection, and management of neuropsychiatric complications: essential components to the optimal treatment of Parkinson's disease

  2019cited by this paper
• Is cannabidiol the ideal drug to treat non-motor Parkinson’s disease symptoms?

  2019cited by this paper
• Self-reported physical activity levels and clinical progression in early Parkinson's disease.

  2019cited by this paper
• Effects of Cognitive Performance and Affective Status on Fatigue in Parkinson's Disease

  2019cited by this paper
• Predicting the onset of freezing of gait: A longitudinal study

  2018cited by this paper
• The effects of anxiety and external attentional focus on postural control in patients with Parkinson's disease

  2018cited by this paper
• Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.

  2018cited by this paper
• Clinical Markers of Anxiety Subtypes in Parkinson Disease

  2018cited by this paper
• The Convergence of Dopamine and α-Synuclein: Implications for Parkinson’s Disease

  2018cited by this paper
• Hyperbaric oxygen treatment for Parkinson's disease with severe depression and anxiety

  2018cited by this paper
• Decreased sleep quality in Parkinson’s patients is associated with higher anxiety and depression prevalence and severity, and correlates with pain intensity and quality

  2018cited by this paper
• Change in Cognition and Other Non-Motor Symptoms With Obstructive Sleep Apnea Treatment in Parkinson Disease

  2018cited by this paper
• Remote delivery of psychological interventions for Parkinson's disease

  2018cited by this paper
• Pharmacological interventions for anxiety in Parkinson’s disease sufferers

  2018cited by this paper
• Assessment of Duodopa® effects on quality of life of patients with advanced Parkinson’s disease and their caregivers

  2018cited by this paper
• Relationships between gait and emotion in Parkinson's disease: A narrative review.

  2018cited by this paper
• Factors associated with spousal burden in Parkinson's disease.

  2018cited by this paper
• How Well Do Caregivers Detect Depression and Anxiety in Patients With Parkinson Disease?

  2018cited by this paper
• Cognitive behavioural therapy for anxiety disorders in Parkinson's disease: Design of a randomised controlled trial to assess clinical effectiveness and changes in cerebral connectivity.

  2018cited by this paper
• Evidence for subtypes of freezing of gait in Parkinson's disease

  2018cited by this paper
• Clinical Predictors of Excessive Daytime Sleepiness in Patients with Parkinson's Disease

  2018cited by this paper
• Frequency of mood and anxiety fluctuations in Parkinson's disease patients with motor fluctuations: A systematic review

  2018cited by this paper
• Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

  2018cited by this paper
• Does nutritional status affect Parkinson's Disease features and quality of life?

  2018cited by this paper
• Efficacy of safinamide on non-motor symptoms in a cohort of patients affected by idiopathic Parkinson’s disease

  2018cited by this paper
• Psychiatric Manifestation in Patients with Parkinson's Disease

  2018cited by this paper
• Factors related to excessive sleepiness in patients with Parkinson’s disease

  2018cited by this paper
• Dietary Variations in a Multiethnic Parkinson's Disease Cohort and Possible Influences on Nonmotor Aspects: A Cross-Sectional Multicentre Study

  2018cited by this paper
• Predictors of anxiety in early-stage Parkinson's disease - Results from the first two years of a prospective cohort study.

  2017cited by this paper
• Detecting anxiety in individuals with Parkinson disease

  2017cited by this paper
• Premotor symptoms and the risk of Parkinson's disease: A case-control study in Mexican population.

  2017cited by this paper
• Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease

  2017cited by this paper
• Mood and neural correlates of excessive daytime sleepiness in Parkinson's disease

  2017cited by this paper
• Response of non-motor symptoms to levodopa in late-stage Parkinson's disease: Results of a levodopa challenge test.

  2017cited by this paper
• Neuropsychiatric Predictors of Cognitive Decline in Parkinson Disease: A Longitudinal Study.

  2017cited by this paper
• A Cross-sectional Analysis of the Characteristics of Individuals With Parkinson Disease Who Avoid Activities and Participation Due to Fear of Falling

  2017cited by this paper
• The bidirectional longitudinal relationship between insomnia, depression and anxiety in patients with early-stage, medication-naïve Parkinson's disease.

  2017cited by this paper
• Gender Differences of Nonmotor Symptoms Affecting Quality of Life in Parkinson Disease

  2017cited by this paper
• Anxiety provokes balance deficits that are selectively dopa-responsive in Parkinson's disease.

  2017cited by this paper
• Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson's disease.

  2017cited by this paper
• Onset and evolution of anxiety in Parkinson's disease

  2017cited by this paper
• The Relation of Anxiety and Cognition in Parkinson’s Disease

  2017cited by this paper
• Cognitive–behavioural therapy for non-motor symptoms of Parkinson's disease: a clinical review

  2017cited by this paper
• Longitudinal assessment of excessive daytime sleepiness in early Parkinson’s disease

  2017cited by this paper
• Motor, behavioural, and cognitive correlates of fatigue in early, de novo Parkinson disease patients.

  2017cited by this paper
• Overload From Anxiety: A Non-Motor Cause for Gait Impairments in Parkinson's Disease.

  2017cited by this paper
• Prevalence and risk factors for depression and anxiety in Chinese patients with Parkinson disease

  2017cited by this paper
• The impact of motor symptoms on self-reported anxiety in Parkinson's disease.

  2017cited by this paper
• The effect of resistance training on the anxiety symptoms and quality of life in elderly people with Parkinson's disease: a randomized controlled trial

  2017cited by this paper
• A comprehensive overview of the neuropsychiatry of Parkinson's disease: A review.

  2017cited by this paper
• Timing and Kinetics of Nonmotor Fluctuations in Advanced Parkinson’s Disease

  2017cited by this paper
• Guidelines for dementia or Parkinson’s disease with depression or anxiety: a systematic review

  2016cited by this paper
• Psychiatric and social outcome after deep brain stimulation for advanced Parkinson's disease

  2016cited by this paper
• Depression and anxiety are co-morbid but dissociable in mild Parkinson's disease: A prospective longitudinal study of patterns and predictors.

  2016cited by this paper
• Clinical Presentation of Anxiety in Parkinson’s Disease

  2016cited by this paper
• Suitability of the Depression, Anxiety, and Stress Scale in Parkinson’s Disease

  2016cited by this paper
• Assessment of Nonmotor Fluctuations Using a Diary in Advanced Parkinson’s disease

  2016cited by this paper
• Prevalence of anxiety in Parkinson's disease: A systematic review and meta‐analysis

  2016cited by this paper
• Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms

  2016cited by this paper
• Factors contributing to malnutrition in patients with Parkinson's disease.

  2016cited by this paper
• Evaluating the Link Between Dopaminergic Treatment, Gait Impairment, and Anxiety in Parkinson's Disease

  2016cited by this paper
• Mood Differences Among Parkinson's Disease Patients With Mild Cognitive Impairment.

  2016cited by this paper
• Depression, anxiety and non-motor symptoms on initiation of intrajejunal levodopa/carbidopa therapy

  2016cited by this paper
• Prevalence, Patterns and Predictors of Psychotropic Polypharmacy Among Elderly Individuals with Parkinson’s Disease In Long Term Care Settings In The United States

  2016cited by this paper
• Psychological Predictors of Anxiety and Depression in Parkinson's Disease: A Systematic Review.

  2016cited by this paper
• Anxiety is associated with freezing of gait and attentional set-shifting in Parkinson's disease: A new perspective for early intervention.

  2016cited by this paper
• Mindfulness for Motor and Nonmotor Dysfunctions in Parkinson's Disease

  2016cited by this paper
• Psychiatric Symptoms in the Initial Motor Stage of Parkinson's Disease.

  2016cited by this paper
• Hospital care for mental health and substance abuse conditions in Parkinson's disease

  2016cited by this paper
• The effects of a mindfulness-based lifestyle program for adults with Parkinson’s disease: a mixed methods, wait list controlled randomised control study

  2016cited by this paper
• Modeling anxiety in Parkinson's disease

  2016cited by this paper
• Disease-specific anxiety symptomatology in Parkinson's disease

  2016cited by this paper
• Restless leg syndrome: a risk factor of higher prevalence of anxiety and depression in Parkinson’s disease patients

  2016cited by this paper
• Neuropsychiatric Complications of Parkinson Disease Treatments: Importance of Multidisciplinary Care.

  2016cited by this paper

• Diagnosis and Management of Parkinson Disease in Individuals with Pre-Existing Mood Disorders.

  2026cites this paper
• Multidimensional mechanisms of anxiety and depression in Parkinson's Disease: integrating neuroimaging, neurocircuits, and molecular pathways.

  2025cites this paper
• Multi-day recordings and adaptive stimulation protocols for in-home collection of deep brain stimulation intracranial recordings.

  2025cites this paper
• Detection of anxiety and depression-like behavior and intra-brain pathological markers in Parkinsonian cynomolgus monkeys.

  2025cites this paper
• Imaging advances to detect non-motor prodromal markers of Parkinson’s disease and explore therapeutic translation opportunities

  2025cites this paper
• Affective phenotypes in heterozygous LRRK2 R1441G knock-in mice

  2025cites this paper
• Cognitive behavioral therapy for anxiety and depression symptoms in people of Parkinson’s disease: a systematic review and meta-analysis

  2025cites this paper
• A Comparative Analysis of Psychiatric Symptoms in Parkinson's Disease Between Tremor-Dominant and Non-Tremor-Dominant Phenotypes.

  2025cites this paper
• Parkinson Disease.

  2025cites this paper
• Levodopa-synergistic CBT intervention improves Parkinson’s disease with anxiety disorder by regulating the BDNF/PI3K/AKT pathway

  2025cites this paper
• Acceptability of and attitudes to the therapeutic use of cannabis and cannabidiol in people with Parkinson’s disease: A French survey

  2024cites this paper
• The zona incerta system: Involvement in Parkinson's disease.

  2024cites this paper
• Progress of non‐motor symptoms in early‐onset Parkinson's disease

  2024cites this paper
• An examination of anxiety and its influence on health-related quality of life in Parkinson’s disease using the geriatric anxiety scale: a cross-sectional study

  2024cites this paper
• A general clinical overview of the non-motor symptoms in Parkinson's disease: Neuropsychiatric symptoms.

  2024cites this paper
• Nuclear localization of alpha-synuclein induces anxiety-like behavior in mice by decreasing hippocampal neurogenesis and pathologically affecting amygdala circuits.

  2023cites this paper
• PARKINSON'S DISEASE OVERVIEW AND LATEST UPDATES IN CLINICAL TRIALS

  year unknowncites this paper